muscle invasive bladder cancer

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

muscle invasive bladder cancer
Nov 25, 2024, 17:19 | Blog
Paul Sargos: TMT and concomitant Chemo regimen for patients with Muscle Invasive Bladder Cancer
Paul Sargos, Head of the Radiology Department at Bergonie Institute, shared a post X about recent…
Nov 1, 2024, 08:06 | Insight
Vérane Achard: Our editorial on the long-term results of the RTOG 0712
Vérane Achard, Radiation Oncologist and Chief Clinical Director at Fribourg Cantonal Hospital, shared a post…
Oct 7, 2024, 08:24 | Insight
Pivotal trial of extended lymphadenectomy vs standard procedure for muscle-invasive bladder cancer
The New England Journal of Medicine shared an article by Seth P. Lerner on X:…
Oct 6, 2024, 13:39 | Insight
Sabine Brookman-May: SWOGS1011 finally published in NEJM
Sabine Brookman-May shared a post on X by NEJM about a recent paper by Seth…
Oct 5, 2024, 23:32 | Insight
AstraZeneca Revealed Positive Results for Muscle Invasive Bladder Cancer Patients at ESMO 2024
IMFINZI (durvalumab) perioperative regimen reduced the risk of recurrence by 32% and the risk of…
Oct 5, 2024, 08:45 | Insight
Extended lymphadenectomy to increase perioperative risks in Muscle-Invasive Bladder Cancer
Yüksel Ürün posted on X: "Extended lymphadenectomy did not improve survival but increased perioperative risks in…
Sep 24, 2024, 13:31 | Blog
Sabine D. Brookman-May: MA supports EFS as a surrogate for OS in Muscle invasive bladder cancer after neoadjuvant treatment
Sabine D. Brookman-May shared a post on X: ''This MA supports Event-free survival as a…
Aug 29, 2024, 16:36 | Blog
Highlights from IBCG24 Retreat
The International Bladder Cancer Group (IBCG) hosted a session at the American Urological Association (AUA)…
Aug 4, 2024, 14:30 | Societies
8 Posts Not To Miss From GUWorld24!
The 2024 World Conference On Genitourinary Cancers (GUWorld24) took place from August 1st to 3rd…
Jul 28, 2024, 09:00 | Insight
Muscle-Invasive Bladder Cancer with ATM, RB1, ERCC2, and FANCC mutations
Yüksel Ürün shared a post on X about a recent paper by Elizabeth Plimack et…
Jul 12, 2024, 13:38 | Blog
Illness script on Treatment of Muscle invasive Bladder cancer
Jordyn Silverstein, Hem/Onc Fellow at UCLA, shared on X: "Illness script: Treatment of Muscle invasive…
Jun 28, 2024, 14:34 | Blog
María Natalia Gandur Quiroga: Imfinzi Shows Significant Survival Benefits in NIAGARA Phase III Trial
María Natalia Gandur Quiroga shared on LinkedIn:   . "Imfinzi Shows Significant Survival Benefits in NIAGARA…
Jun 27, 2024, 14:43 | Insight
Amol Akhade: Landscape for urothelial carcinoma treatment is rapidly evolving
Amol Akhade shared on X: "The landscape for urothelial carcinoma treatment is rapidly evolving. Now…
Jun 27, 2024, 14:17 | Insight
Mohit Manrao: Positive high-level results from the NIAGARA Phase 3 study with IO in MIBC
Mohit Manrao, SVP, Head of US Oncology at AstraZeneca, shared on LinkedIn: “This content is…
Jun 26, 2024, 15:22 | Insight
Results from the NIAGARA Phase III trial
AztraZeneca released the results of the NIAGARA phase III trial, where INFINZI (durvalumab) showed EFS…
Jun 26, 2024, 13:51 | Insight
Tom Powles: Durvalumab with neoadjuvant chemo then cystectomy in MIBC
Tom Powles shared on X: "Positive results from the NIAGARA Phase III trial showed durvalumab…
Jun 6, 2024, 11:43 | Blog
Professor Andrea Necchi on the clinical impact of NMIBC progression to MIBC- Media Medic
MediaMedic posted on LinkedIn: "At the recent ESMO Congress, significant discussions were held on the…
May 21, 2024, 12:45 | Insight
Enrique Grande: Improving antitumor immune response via Treg reduction in bladder cancer
Enrique Grande, Head of the Medical Oncology Service and Director of Clinical Research at the MD…
May 6, 2024, 06:40 | Insight
Stefano Arcangeli: Time to give TMT equal billing to RC in clinical practice
Stefano Arcangeli, Radiation Oncologist and Associate Professor at the University of Milan-Bicocca, shared a post…
Apr 28, 2024, 19:14 | Insight
Andrea Necchi: Pleased to see the interim results of SURE01 trial slated for presentation at ASCO24
Andrea Necchi, Associate Professor at Vita-Salute San Raffaele University, shared on LinkedIn: "Very pleased to…
Apr 8, 2024, 22:27 | Insight
Adjuvant Therapy for Urothelial Cancer in Advances in Oncology - New Paper Alert!
Adjuvant Therapy for Muscle-Invasive Urothelial Cancer: Current Evidence and Future Directions   Authors: Charbel Hobeika,…
Jan 30, 2024, 15:45 | Societies
Chiara Mercinelli: An honor to present Nure Combo trial at ASCO GU24
Chiara Mercinelli, Fellow Research Oncology Resident IRCCS San Raffaele, posted on X/Twitter: "It has been…
All: 22 Posts: 1 - 100
Special Coverage